ukmla MCQ (SBA): Prostate Cancer Treatment Flare Prevention

Instant feedback + full explanation. One question, done properly.

MediumOncologyProstate Cancer Treatment Flare Preventionukmlamrcgp aktprescribing safety assessmentmrcp part 1

A 70-year-old man is diagnosed with metastatic prostate cancer. He is experiencing significant bone pain. His oncologist decides to start him on a luteinizing hormone-releasing hormone (LHRH) agonist. Which of the following medications should be co-prescribed for the first few weeks of LHRH agonist treatment to prevent tumour flare?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.